doi:10.16150/j.1671-2870.2020.02.018

Abstract

CLC Number:

R735.3

Figures/Tables 8

References 17

[1]	Fakhri B, Kahl B. Current and emerging treatment options for mantle cell lymphoma[J]. Ther Adv Hematol, 2017, 8(8):223-234. doi: 10.1177/2040620717719616 pmid: 28811872
[2]	Vose JM. Mantle cell lymphoma: 2017 update on diagnosis, risk-stratification, and clinical management[J]. Am J Hematol, 2017, 92(8):806-813. doi: 10.1002/ajh.24797 URL
[3]	陈灏珠, 林果为, 王吉耀, 等. 实用内科学[M]. 14版. 北京: 人民卫生出版社, 2013:2438-2439.
[4]	Matutes E, Parry-Jones N, Brito-Babapulle V, et al. The leukemic presentation of mantle-cell lymphoma: disease features and prognostic factors in 58 patients[J]. Leuk Lymphoma, 2004, 45(10):2007-2015. doi: 10.1080/10428190410001723331 URL
[5]	平凌燕, 郑文, 王小沛, 等. 98例套细胞淋巴瘤临床特点及预后分析[J]. 中国肿瘤临床, 2014, 41(19):1234-1238.
[6]	Tiemann M, Schrader C, Klapper W, et al. Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL Network[J]. Br J Haematol, 2005, 131(1):29-38. doi: 10.1111/j.1365-2141.2005.05716.x URL
[7]	Dasappa L, Suresh Babu MC, Sirsath NT, et al. Primary gastrointestinal mantle cell lymphoma: a retrospective study[J]. J Gastrointest Cancer, 2014, 45(4):481-486. doi: 10.1007/s12029-014-9655-2 URL
[8]	Khuroo MS, Khwaja SF, Rather A, et al. Clinicopathological profile of gastrointestinal lymphomas in Kashmir[J]. Indian J Med Paediatr Oncol, 2016, 37(4):251-255. doi: 10.4103/0971-5851.195736 URL
[9]	Howell JM, Auer-Grzesiak I, Zhang J, et al. Increasing incidence rates, distribution and histological characteristics of primary gastrointestinal non-Hodgkin lymphoma in a North American population[J]. Can J Gastroenterol, 2012, 26(7):452-456. doi: 10.1155/2012/480160 URL
[10]	Radić-Krišto D, Planinc-Peraica A, Ostojić S, et al. Primary gastrointestinal non-Hodgkin lymphoma in adults: clinicopathologic and survival characteristics[J]. Coll Antropol, 2010, 34(2):413-417. pmid: 20698111
[11]	Shannon EM, MacQueen IT, Miller JM, et al. Management of Primary Gastrointestinal Non-Hodgkin Lymphomas: a Population-Based Survival Analysis[J]. J Gastrointest Surg, 2016, 20(6):1141-1149. doi: 10.1007/s11605-016-3129-8 URL
[12]	Baheti AD, Tirumani SH, Sewatkar R, et al. MDCT of extranodal mantle cell lymphoma: a single institute experience[J]. Abdom Imaging, 2015, 40(6):1693-1699. doi: 10.1007/s00261-015-0389-9 URL
[13]	Hu C, Yi C, Dai X. Clinical study of 31 patients with primary gastric mucosa-associated lymphoid tissue lymphoma[J]. J Gastroenterol Hepatol, 2006, 21(4):722-726. doi: 10.1111/j.1440-1746.2006.04249.x URL
[14]	Martin P, Ghione P, Dreyling M. Mantle cell lymphoma - Current standards of care and future directions[J]. Cancer Treat Rev, 2017, 58:51-60. doi: S0305-7372(17)30097-X pmid: 28651117
[15]	Spurgeon SE, Till BG, Martin P, et al. Recommendations for Clinical Trial Development in Mantle Cell Lymphoma[J]. J Natl Cancer Inst, 2016, 109(1):263.
[16]	Fakhri B, Kahl B. Current and emerging treatment options for mantle cell lymphoma[J]. Ther Adv Hematol, 2017, 8(8):223-234. doi: 10.1177/2040620717719616 pmid: 28811872
[17]	Rule S, Dreyling M, Goy A, et al. Outcomes in 370 patients with mantle cell lymphoma treated with ibrutinib: a pooled analysis from three open-label studies[J]. Br J Haematol, 2017, 179(3):430-438. doi: 10.1111/bjh.14870 URL

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 8

References 17

Related Articles 8

Recommended Articles

Metrics

Comments

[1]	LI Lei, YUAN Fei, WANG Chaofu, XU Haimin, WANG Ting. Ampullary adenocarcinoma: analysis of the clinicopathological features and prognostic factors [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(03): 355-361.
[2]	. [J]. Journal of Diagnostics Concepts & Practice, 2021, 20(06): 584-587.
[3]	ZHANG Hua, LU Wei, YANG Chengyi, XIANG Mingjie. Value of serum FBLN1 detection in diagnosis and prognosis prediction of colorectal cancer [J]. Journal of Diagnostics Concepts & Practice, 2021, 20(05): 462-465.
[4]	. [J]. Journal of Diagnostics Concepts & Practice, 2019, 18(04): 383-386.
[5]	WANG Ziyuan, LIANG Tingyu, CHEN Jia, HAN Zhihong, WU Lili. Analysis of KRAS, NRAS and BRAF mutations in colorectal cancer and their correlation with clinicopathologic features and p53 protein expression [J]. Journal of Diagnostics Concepts & Practice, 2018, 17(06): 687-693.
[6]	WU Chao, XU Chenying, XU Qingling, TANG Chenyue, YU Lifen. Optimization of screening potential candidates for use of aspirin as primary prevention in health check-up male subjects aged 50-59 years based on the results of endoscopy [J]. Journal of Diagnostics Concepts & Practice, 2017, 16(02): 171-177.
[7]	JIANG Meijiao, ZHAN Weiwei, CHEN Hui, XU Ruiyun, YANG Zhifang, LIU juan. Misdiagnosis of low position intestinal tumors in women by ultrasonography [J]. Journal of Diagnostics Concepts & Practice, 2017, 16(01): 109-113.
[8]	CHEN Ying, HE Lili, JIANG Feng. Expression of long non-coding RNA FENDRR in human colorectal cancer and its correlation with prognosis [J]. Journal of Diagnostics Concepts & Practice, 2018, 17(01): 87-91.